Moderna and rival Pfizer on Wednesday said their updated Covid-19 vaccines generated strong responses in testing against the highly mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections. Moderna said its shot generated an 8.7-fold increase in neutralising antibodies against BA.2.86 compared with an[…]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.